High Triglycerides Breakthrough Therapy: Icosapent Ethyl

March 8, 2021 University of Best Practices

      • Agenda|Bios|Video
      • Welcome and Statewide Updates (Presentation|Video)
        • Hattie Rees Hanley, MPP – Director and Founder, Right Care Initiative, Center for Healthcare Organizational and Innovation Research, UC Berkeley School of Public Health
        • Steven Chen, PharmD, FASHP, FCSHP, FNAP – Co-Chair, Right Care Initiative Los Angeles University of Best Practices; Associate Dean for Clinical Affairs; William A. and Josephine A. Heeres Chair in Community Pharmacy; Associate Professor of Clinical Pharmacy, University of Southern California
        • Scott Flinn, MD – Co-Founder, Right Care Initiative University of Best Practices; Regional Medical Director, Blue Shield of California; Former US Navy Undersea Medical Officer with the Navy Seals
        • Susan L. Ivey, MD, MHSA – Co-Chair, Right Care Initiative Capital Region University of Best Practices; Professor, Adjunct, School of Public Health, UC Berkeley; Director of Research, Health Research for Action
        • Joseph Sky, MD, FACP, FACC – Co-Chair, Right Care Initiative University of Best Practices; Chief of Preventive Cardiology, Associate Chief of Staff, David Grant Medical Center, US Air Force
        • Eveline Stock, MD – Co-Chair, Right Care Initiative Bay Area Silicon Valley University of Best Practices; Assistant Professor and Cardiologist, University of California San Francisco Cardiovascular Care & Prevention Center
      • Introduction to Residual Risk Topics and Talks (Presentation|Video)
        • William J. Bommer, MD, FACP, FACC – Statewide Chairman, Right Care Initiative University of Best Practices; Specialty Delegate, California American College of Cardiology and California Medical Association; Director, California ePCI Program; Director, Prevention Forward Program and Professor of Medicine, Division of Cardiovascular Medicine, University of California, Davis
      • The REDUCE-IT Trial (Presentation|Video)
        • Deepak Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC– Executive Director of Interventional Cardiovascular Programs; Professor, Harvard Medical School; Principal Investigator, REDUCE-IT Trial
      • Eligibility and Preventable Cardiovascular Events in US Population (Presentation|Video)
        • Nathan Wong, PhD, MPH, FACC, FAHA, FNLA, FASPC – Professor, School of Medicine & Department of Epidemiology; Director, UCI Heart Disease Prevention Program, School of Medicine; University of California, Irvine
      • Cost-Effectiveness of Icosapent Ethyl (Presentation|Video)
        • William J. Bommer, MD, FACP, FACC – Statewide Chairman, Right Care Initiative University of Best Practices; Specialty Delegate, California American College of Cardiology and California Medical Association; Director, California ePCI Program; Director, Prevention Forward Program and Professor of Medicine, Division of Cardiovascular Medicine, University of California, Davis
      • Q&A and Discussion (Video)